ZERBAXA

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug ZERBAXA contains a combination of these active pharmaceutical ingredients (APIs):

1 Ceftolozane UNII 7R247U84HY - CEFTOLOZANE SULFATE

Ceftolozane belongs to the cephalosporin class of antimicrobials. Ceftolozane exerts bactericidal activity through binding to important penicillin-binding proteins (PBPs), resulting in inhibition of bacterial cell-wall synthesis and subsequent cell death. Read about Ceftolozane

2 Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM

Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes. Read about Tazobactam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DI54		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DI Other cephalosporins
Discover more medicines within J01DI54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02446901
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2658-MEE-0417
Country: EE	Ravimiamet	Identifier(s): 1697351
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1151032001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 392550
Country: FR	Base de données publique des médicaments	Identifier(s): 65166404
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 310081
Country: HK	Department of Health Drug Office	Identifier(s): 65156
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8697
Country: IT	Agenzia del Farmaco	Identifier(s): 044506018
Country: JP	医薬品医療機器総合機構	Identifier(s): 6139506D1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1078169
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 023M2017
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 128430
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17340
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100354781
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64654001
Country: SG	Health Sciences Authority	Identifier(s): 15317P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636261385
Country: US	FDA, National Drug Code	Identifier(s): 67919-030